Enanta Pharmaceuticals (ENTA) News Today → 4x Better than Bitcoin (From Behind the Markets) (Ad) Free ENTA Stock Alerts $17.46 +0.93 (+5.63%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Rating of "Hold" from Brokeragesamericanbankingnews.com - March 26 at 2:54 AMEnanta Pharmaceuticals Incmoney.usnews.com - March 19 at 2:01 PMWalleye Capital LLC Acquires 92,410 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)marketbeat.com - March 19 at 4:22 AMENTA Enanta Pharmaceuticals, Inc.seekingalpha.com - March 13 at 3:26 PMENTA Oct 2024 20.000 callfinance.yahoo.com - March 11 at 1:01 PMENTA Oct 2024 22.500 callfinance.yahoo.com - March 11 at 8:00 AMENTA Oct 2024 10.000 putfinance.yahoo.com - March 11 at 8:00 AMEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conferencebusinesswire.com - March 6 at 7:00 AMShort Interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Rises By 20.1%marketbeat.com - March 5 at 2:52 PMTrexquant Investment LP Takes Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)marketbeat.com - March 4 at 6:30 AMJanney Montgomery Scott LLC Buys New Shares in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)marketbeat.com - February 24 at 4:17 AMAcadian Asset Management LLC Buys 448,201 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)marketbeat.com - February 23 at 7:35 AMShort Interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Rises By 15.7%marketbeat.com - February 16 at 8:19 PMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Reportfinance.yahoo.com - February 12 at 8:51 AMOppenheimer Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA)markets.businessinsider.com - February 9 at 2:34 PMMaintaining Hold on Enanta Pharmaceuticals Amid Near-Term Challenges and Pipeline Potentialmarkets.businessinsider.com - February 9 at 9:34 AMBank of New York Mellon Corp Has $1.21 Million Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)marketbeat.com - February 9 at 4:22 AMQ1 2024 Enanta Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 8 at 9:43 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - February 8 at 9:43 AMLeerink Partnrs Comments on Enanta Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ENTA)marketbeat.com - February 8 at 7:46 AMRecap: Enanta Pharma Q1 Earningsbenzinga.com - February 7 at 9:01 PMEnanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...finance.yahoo.com - February 7 at 9:01 PMEnanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimatesfinance.yahoo.com - February 7 at 9:01 PMEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ETbusinesswire.com - February 7 at 4:09 PMLeerink Partnrs Weighs in on Enanta Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ENTA)marketbeat.com - February 7 at 8:06 AMEarnings Preview For Enanta Pharmabenzinga.com - February 6 at 9:13 PMEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 8:25 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Hold" by Brokeragesmarketbeat.com - February 5 at 1:42 AMEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023finance.yahoo.com - January 31 at 8:25 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Purchased by Assenagon Asset Management S.A.marketbeat.com - January 30 at 5:59 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Sees Significant Decline in Short Interestmarketbeat.com - January 16 at 11:37 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from Analystsmarketbeat.com - January 11 at 2:36 AMBuy Rating on Enanta Pharmaceuticals Amidst Promising RSV Program Developments and Strategic Expansion into CSU Marketmarkets.businessinsider.com - January 5 at 8:27 AMStrength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?finance.yahoo.com - January 5 at 8:27 AMEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 4 at 10:07 AMEnanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.commarketbeat.com - December 19 at 10:17 PMInsider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)finance.yahoo.com - December 16 at 8:23 AMTerry Vance Sells 15,295 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stockmarketbeat.com - December 15 at 9:23 PMWall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Knowfinance.yahoo.com - December 13 at 3:47 PMWall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Knowfinance.yahoo.com - December 13 at 3:47 PMHow Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%finance.yahoo.com - November 27 at 4:46 PMEnanta Pharma Stock (NASDAQ:ENTA) Insider Tradesbenzinga.com - November 23 at 3:43 PMEnanta Pharma Stock (NASDAQ:ENTA) Earnings Dates and Earning Callsbenzinga.com - November 22 at 10:58 PMEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conferencefinance.yahoo.com - November 22 at 7:57 AMEnanta Pharmaceuticals Shares Rise 21% After Slashing Spending Guidancemarketwatch.com - November 21 at 3:22 PMWhat 5 Analyst Ratings Have To Say About Enanta Pharmamarkets.businessinsider.com - November 21 at 10:21 AMQ4 2023 Enanta Pharmaceuticals Inc Earnings Callfinance.yahoo.com - November 21 at 10:21 AMEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - November 21 at 10:21 AMRecap: Enanta Pharma Q4 Earningsbenzinga.com - November 20 at 6:01 PMEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ETfinance.yahoo.com - November 20 at 6:01 PM Get Enanta Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTA and its competitors with MarketBeat's FREE daily newsletter. Email Address 4x Better than Bitcoin (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> ENTA Media Mentions By Week ENTA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENTA News Sentiment▼0.740.61▲Average Medical News Sentiment ENTA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENTA Articles This Week▼32▲ENTA Articles Average Week Get Enanta Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RAPT News Today XOMA News Today NBTX News Today XERS News Today ERAS News Today GOSS News Today ATAI News Today ANNX News Today PRLD News Today KMDA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENTA) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.